| Drug repositioning: new approaches and future prospects for life-debilitating diseases and the COVID-19 pandemic outbreak ZY Low, IA Farouk, SK Lal Viruses 12 (9), 1058, 2020 | 94 | 2020 |
| Repositioning Ivermectin for COVID-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication ZY Low, AJW Yip, SK Lal Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (2), 166294, 2022 | 43 | 2022 |
| SARS-CoV-2 non-structural proteins and their roles in host immune evasion ZY Low, NZ Zabidi, AJW Yip, A Puniyamurti, VTK Chow, SK Lal Viruses 14 (9), 1991, 2022 | 35 | 2022 |
| Repurposing molnupiravir for COVID-19: the mechanisms of antiviral activity AJW Yip, ZY Low, VTK Chow, SK Lal Viruses 14 (6), 1345, 2022 | 28 | 2022 |
| SARS coronavirus outbreaks past and present—a comparative analysis of SARS-CoV-2 and its predecessors ZY Low, AJW Yip, A Sharma, SK Lal Virus Genes 57 (4), 307-317, 2021 | 26 | 2021 |
| Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies NZ Zabidi, HL Liew, IA Farouk, A Puniyamurti, AJW Yip, VN Wijesinghe, ... Viruses 15 (4), 944, 2023 | 23 | 2023 |
| The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID‐19 disease progression ZY Low, AJ Wen Yip, VTK Chow, SK Lal Reviews in medical virology 32 (3), e2300, 2022 | 13 | 2022 |
| Repositioning anticancer drugs as novel COVID-19 antivirals: Targeting structural and functional similarities between viral proteins and cancer ZY Low, AJW Yip, SK Lal Expert Reviews in Molecular Medicine 24, e20, 2022 | 4 | 2022 |
| The Novel SARS-CoV-2: An Overview on its Detection, Prevention and Control A Sharma, ZY Low, SK Lal, VTK Chow Uncovering The Science Of Covid-19, 1-28, 2023 | 2 | 2023 |
| The convergent evolution of influenza A virus: Implications, therapeutic strategies and what we need to know ZY Low, KH Wong, AJW Yip, WS Choo Current research in microbial sciences, 100202, 2023 | 1 | 2023 |
| Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19 KH Wong, CM Lim, AJW Yip, IA Farouk, NZ Zabidi, ZY Low, SK Lal Drug Repurposing for Emerging Infectious Diseases and Cancer, 423-450, 2023 | 1 | 2023 |
| 6 The Molecular Biology of SARS-CoV-2 and Its Evolving Variants ZY Low, AJW Yip, SK Lal Learning from the COVID-19 Pandemic: Implications for Science, Health, and …, 2023 | | 2023 |
| Genomic Approaches for Drug Repositioning IA Farouk, ZY Low, A Puniyamurti, NZ Zabidi, MKA Amin, SK Lal Biomedical Translational Research: Drug Design and Discovery, 49-72, 2022 | | 2022 |
| Deregulation of the Host Cell Cycle Induced by SARS‐CoV‐2 Nucleocapsid Protein CSA Wong, IA Farouk, ZY Low, SK Lal, JW Tan Asia-Pacific Journal of Molecular Biology and Biotechnology, 50-50, 2022 | | 2022 |
| Studies on the Role of SARS-CoV-2 Nucleocapsid as an Interferon Antagonist AL Wong, IA Farouk, ZY Low, SK Lal Asia-Pacific Journal of Molecular Biology and Biotechnology, 81-81, 2022 | | 2022 |
| PABPC1: A Novel Emerging Target for Cancer Prognostics and Anti-cancer IA Farouk, ZY Low, AJW Yip, SK Lal Molecular Biomarkers for Cancer Diagnosis and Therapy, 619, 0 | | |
